Array Bridge is testing promising drug candidates that can effectively bind and even degrade target proteins, but not via their active sites.

Polycystic ovary syndrome (PCOS) represents a significant health concern for women of reproductive age, manifesting as a ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions ...

University of Pittsburgh researchers discovered that a mix of growth factors can rescue cells from late-stage anthrax damage ...

These included MEK1 and MEK2, which control a pathway called ERK involved in cellular division and survival, and MEK3 and MEK6, which regulate the p38 pathway that's involved in stress-induced defense ...

Results provide proof-of-concept that ERK pathway reactivation might be an effective, biologically based therapy to prevent anthrax-induced lethality.

The use of anthrax as a bioweapon is rare, but devastating. This new treatment might one day save people that are beyond the ...

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once ...